Clinical Trials Sponsored by Aposense Ltd.

Total 16953 results

Aposense Ltd.

Terminated

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Metastasis to Brain of Unknown Primary
Aposense Ltd.

Unknown

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Solid Tumors | Brain Metastases

United States
Aposense Ltd.

Completed

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

Solid Tumors | Brain Metastases
Aposense Ltd.

Unknown

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung

United States
BioSense Medical LTD
Sheba Medical Center

Unknown

Non Invasive Detection of Lung and Breast Cancer by Odor Signature

Breast Cancer | Lung Cancer

Israel
Rhythm AI Ltd
Biosense Webster, Inc.

Withdrawn

RandOmised Controlled Trial of STAR Mapping™ Guided Ablation for AF. (ROC-STAR)

Atrial Fibrillation
Biosense Webster EMEA

Terminated

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (CACAF-2)

Atrial Fibrillation

Italy, United Kingdom, Finland
Neosense Technologies

Terminated

Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients (IMPROVE)

Newborn, Infant, Disease | Oxygen Saturation | Catheters

Sweden
BaroSense Inc.

Withdrawn

Safety and Preliminary Effectiveness of the BaroSense Articulating Circular Endoscopic (ACE) Stapler for Plication of Dilated Post-surgical Gastric Anatomy

Obese
Biosense Webster EMEA

Completed

FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)

Atrial Fibrillation

Italy
Neosense Technologies

Terminated

Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2 (IMPROVE-2)

Lung Diseases | Catheter | Newborn, Infant, Disease

Sweden
BaroSense Inc.

Completed

Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity

Obesity

Canada
Biosense Webster EMEA

Completed

European Carto® XP REgistry for Validating Specialized CFAE SOftware (EXPRESSO)

Atrial Fibrillation

France, Germany, Hungary
Biosense Webster, Inc.

Recruiting

A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS (PulseSmart)

Atrial Fibrillation

Australia, Canada
Biosense Webster, Inc.

Recruiting

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator (Omny-IRE)

Atrial Fibrillation

Belgium, Canada, Netherlands, Lithuania, Croatia, Germany, Italy, Czechia
Biosense Webster, Inc.

Active, not recruiting

A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF) (AFIRE)

Refractory Paroxysmal Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation (Q-FFICIENCY)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

Multi-electrode Radiofrequency Balloon Catheter Use for the Isolation of the Pulmonary Veins. (SHINE)

Paroxysmal Atrial Fibrillation

United Kingdom, Italy, Czechia
Biosense Webster, Inc.

Terminated

Atrial Fibrillation Progression Trial (ATTEST)

Atrial Fibrillation

Korea, Republic of, Germany, Belgium, Norway, Austria, Ireland, United Kingdom, Australia, Spain, Sweden, Latvia, Hungary, Italy, Poland, Russian Federation
Biosense Webster, Inc.

Completed

Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF (RAPID-AF)

Persistent Atrial Fibrillation

United Kingdom, Belgium, Czechia, Canada
Biosense Webster, Inc.

Completed

Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)

Persistent Atrial Fibrillation

United Kingdom, Italy
Biosense Webster, Inc.

Terminated

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Atrial Fibrillation

United States, United Kingdom, Italy, Czechia, Belgium, Hungary
Biosense Webster, Inc.

Completed

SMART China, A Multi-center Clinical Registry Study

Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

FIND CAN Trial: "CF-172" (FIND CAN)

Persistent Atrial Fibrillation

Canada
Biosense Webster, Inc.

Terminated

Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation (CO1)

Paroxysmal Atrial Fibrillation

Canada
Biosense Webster, Inc.

Withdrawn

CARTO 3 Human Patch Study (Human Patch)

Healthy
Biosense Webster, Inc.

Completed

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia (EZCF-125)

Atrial Fibrillation | Ischemic Ventricular Tachycardia

Czech Republic
Biosense Webster, Inc.

Terminated

Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®) (CLARITY-AF)

Atrial Fibrillation

Netherlands, Belgium, Canada, Denmark, Germany, United Kingdom
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Registry

Symptomatic Atrial Fibrillation

Belgium, Germany, United Kingdom, Canada, Australia, France, Italy, Monaco
Biosense Webster, Inc.

Completed

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)

Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Italy, Israel
Biosense Webster, Inc.

Completed

A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter (COSMOS)

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Belgium, Italy
Biosense Webster, Inc.

Completed

Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE) (inspIRE)

Atrial Fibrillation

Canada, Belgium, Austria, Croatia, Czechia, France, Italy, Lithuania
Biosense Webster, Inc.

Completed

Performance of QDOT Micro™ Catheter With nGEN Generator for Patients With AFIB.

Atrial Fibrillation

Canada
Biosense Webster, Inc.

Completed

Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF) (PRECEPT)

Atrial Fibrillation

United States, Canada
Biosense Webster, Inc.

Terminated

Oral Anticoagulation Therapy Pilot Study (OAT)

Paroxysmal Atrial Fibrillation

United States, Germany, Italy, France
Biosense Webster, Inc.

Completed

Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation. (QDOT-FAST)

Paroxysmal Atrial Fibrillation

Belgium, Czechia, Austria, Italy
Biosense Webster, Inc.

Completed

Evaluation of Ablation Index and VISITAG™ (ABI-173) (VISTAX)

Paroxysmal Atrial Fibrillation

Denmark, Netherlands, United Kingdom, France, Belgium, Austria, Ireland, Italy, Switzerland
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry (AF Registry)

Paroxysmal Atrial Fibrillation

United States, Canada
Biosense Webster, Inc.

Completed

Identification for the Treatment of Complex Arrhythmias

Arrhythmias

Belgium, Czechia
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation (Afib IDE)

Heart Diseases | Atrial Fibrillation | Arrhythmia

United States, Italy, Brazil, Canada, Czechia
Biosense Webster, Inc.

Terminated

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators (ASPIRE)

Ventricular Tachycardia | Ischemic

United States
Biosense Webster, Inc.

Completed

REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation (REVOLUTION)

Paroxysmal Atrial Fibrillation

Czechia, Belgium, Denmark, France, Germany, Italy
Biosense Webster, Inc.

Completed

Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man

Arrhythmias

Czech Republic, Belgium
Biosense Webster, Inc.

Completed

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study (SFAF)

Atrial Fibrillation | Paroxysmal Arrhythmia

United States
Biosense Webster, Inc.

Completed

CARTO® 3 System and Real Time Intracardiac Ultrasound (IUAF)

Atrial Fibrillation | Paroxysmal AF

United States
Biosense Webster, Inc.

Terminated

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study (AFTX)

Heart Diseases | Atrial Fibrillation | Arrhythmia

United States
Biosense Webster, Inc.

Completed

Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter

Atrial Flutter

United States

3

Subscribe